• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

过氧化物酶体增殖物激活受体(PPARs)与骨骼肌健康和消耗中的微生物群。

PPARs and Microbiota in Skeletal Muscle Health and Wasting.

机构信息

Department of Pharmaceutical Sciences, University of South Florida, 12901 Bruce B. Downs Blvd., Tampa, FL 33612, USA.

Department of Nutritional Sciences, University of Vienna, Althanstrasse 14, 1090 Vienna, Austria.

出版信息

Int J Mol Sci. 2020 Oct 29;21(21):8056. doi: 10.3390/ijms21218056.

DOI:10.3390/ijms21218056
PMID:33137899
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7662636/
Abstract

Skeletal muscle is a major metabolic organ that uses mostly glucose and lipids for energy production and has the capacity to remodel itself in response to exercise and fasting. Skeletal muscle wasting occurs in many diseases and during aging. Muscle wasting is often accompanied by chronic low-grade inflammation associated to inter- and intra-muscular fat deposition. During aging, muscle wasting is advanced due to increased movement disorders, as a result of restricted physical exercise, frailty, and the pain associated with arthritis. Muscle atrophy is characterized by increased protein degradation, where the ubiquitin-proteasomal and autophagy-lysosomal pathways, atrogenes, and growth factor signaling all play an important role. Peroxisome proliferator-activated receptors (PPARs) are members of the nuclear receptor family of transcription factors, which are activated by fatty acids and their derivatives. PPARs regulate genes that are involved in development, metabolism, inflammation, and many cellular processes in different organs. PPARs are also expressed in muscle and exert pleiotropic specialized responses upon activation by their ligands. There are three PPAR isotypes, viz., PPARα, -β/δ, and -γ. The expression of PPARα is high in tissues with effective fatty acid catabolism, including skeletal muscle. PPARβ/δ is expressed more ubiquitously and is the predominant isotype in skeletal muscle. It is involved in energy metabolism, mitochondrial biogenesis, and fiber-type switching. The expression of PPARγ is high in adipocytes, but it is also implicated in lipid deposition in muscle and other organs. Collectively, all three PPAR isotypes have a major impact on muscle homeostasis either directly or indirectly. Furthermore, reciprocal interactions have been found between PPARs and the gut microbiota along the gut-muscle axis in both health and disease. Herein, we review functions of PPARs in skeletal muscle and their interaction with the gut microbiota in the context of muscle wasting.

摘要

骨骼肌是一种主要的代谢器官,主要利用葡萄糖和脂质来产生能量,并具有响应运动和禁食进行自身重塑的能力。许多疾病和衰老过程中都会发生骨骼肌减少症。肌肉减少症通常伴随着慢性低度炎症,伴随着肌肉内和肌肉间脂肪沉积。随着年龄的增长,由于运动障碍增加、体力活动受限、虚弱以及关节炎相关疼痛,肌肉减少症会进一步加重。肌肉萎缩的特征是蛋白质降解增加,其中泛素蛋白酶体和自噬溶酶体途径、肌萎缩基因和生长因子信号转导都起着重要作用。过氧化物酶体增殖物激活受体 (PPARs) 是核受体转录因子家族的成员,它们被脂肪酸及其衍生物激活。PPARs 调节参与不同器官发育、代谢、炎症和许多细胞过程的基因。PPARs 也在肌肉中表达,并在其配体激活时发挥多效性的特殊反应。有三种 PPAR 同工型,即 PPARα、-β/δ 和 -γ。PPARα 在具有有效脂肪酸分解代谢的组织中表达较高,包括骨骼肌。PPARβ/δ 表达更广泛,是骨骼肌中的主要同工型。它参与能量代谢、线粒体生物发生和纤维型转换。PPARγ 在脂肪细胞中表达较高,但它也与肌肉和其他器官中的脂质沉积有关。总的来说,所有三种 PPAR 同工型都直接或间接地对肌肉稳态产生重大影响。此外,在健康和疾病状态下,已经发现 PPARs 与肠道微生物群之间存在沿肠道-肌肉轴的相互作用。本文综述了 PPARs 在骨骼肌中的功能及其与肌肉减少症背景下肠道微生物群的相互作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e377/7662636/dcfd39ff5d73/ijms-21-08056-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e377/7662636/ec1412324463/ijms-21-08056-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e377/7662636/f8dbf49c38d7/ijms-21-08056-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e377/7662636/dcfd39ff5d73/ijms-21-08056-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e377/7662636/ec1412324463/ijms-21-08056-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e377/7662636/f8dbf49c38d7/ijms-21-08056-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e377/7662636/dcfd39ff5d73/ijms-21-08056-g003.jpg

相似文献

1
PPARs and Microbiota in Skeletal Muscle Health and Wasting.过氧化物酶体增殖物激活受体(PPARs)与骨骼肌健康和消耗中的微生物群。
Int J Mol Sci. 2020 Oct 29;21(21):8056. doi: 10.3390/ijms21218056.
2
The peroxisome proliferator-activated receptor beta/delta agonist, GW501516, regulates the expression of genes involved in lipid catabolism and energy uncoupling in skeletal muscle cells.过氧化物酶体增殖物激活受体β/δ激动剂GW501516可调节骨骼肌细胞中参与脂质分解和能量解偶联的基因表达。
Mol Endocrinol. 2003 Dec;17(12):2477-93. doi: 10.1210/me.2003-0151. Epub 2003 Oct 2.
3
Roles of Peroxisome Proliferator-Activated Receptor β/δ in skeletal muscle physiology.过氧化物酶体增殖物激活受体β/δ在骨骼肌生理学中的作用。
Biochimie. 2017 May;136:42-48. doi: 10.1016/j.biochi.2016.11.010. Epub 2016 Dec 2.
4
Peroxisome proliferator-activated receptors and the control of inflammation.过氧化物酶体增殖物激活受体与炎症控制
Curr Drug Targets Inflamm Allergy. 2002 Sep;1(3):243-8. doi: 10.2174/1568010023344616.
5
Are peroxisome proliferator-activated receptors involved in skeletal muscle wasting during experimental cancer cachexia? Role of beta2-adrenergic agonists.过氧化物酶体增殖物激活受体是否参与实验性癌症恶病质期间的骨骼肌消耗?β2-肾上腺素能激动剂的作用。
Cancer Res. 2007 Jul 1;67(13):6512-9. doi: 10.1158/0008-5472.CAN-07-0231.
6
Peroxisome proliferator-activated receptor (PPAR)β/δ, a possible nexus of PPARα- and PPARγ-dependent molecular pathways in neurodegenerative diseases: Review and novel hypotheses.过氧化物酶体增殖物激活受体 (PPAR)β/δ,神经退行性疾病中 PPARα 和 PPARγ 依赖的分子途径的可能连接点:综述和新假说。
Neurochem Int. 2013 Oct;63(4):322-30. doi: 10.1016/j.neuint.2013.06.012. Epub 2013 Jun 25.
7
Pivotal Roles of Peroxisome Proliferator-Activated Receptors (PPARs) and Their Signal Cascade for Cellular and Whole-Body Energy Homeostasis.过氧化物酶体增殖物激活受体 (PPARs)及其信号级联在细胞和全身能量稳态中的关键作用。
Int J Mol Sci. 2018 Mar 22;19(4):949. doi: 10.3390/ijms19040949.
8
Multifaceted roles of peroxisome proliferator-activated receptors (PPARs) at the cellular and whole organism levels.过氧化物酶体增殖物激活受体 (PPARs) 在细胞和整体水平上的多方面作用。
Swiss Med Wkly. 2010 Sep 15;140:w13071. doi: 10.4414/smw.2010.13071. eCollection 2010.
9
Peroxisome proliferator-activated receptors (PPARs) and the human skin: importance of PPARs in skin physiology and dermatologic diseases.过氧化物酶体增殖物激活受体(PPARs)与人体皮肤:PPARs在皮肤生理学和皮肤病中的重要性
Am J Clin Dermatol. 2008;9(1):15-31. doi: 10.2165/00128071-200809010-00002.
10
Regulation of energy metabolism by long-chain fatty acids.长链脂肪酸对能量代谢的调控。
Prog Lipid Res. 2014 Jan;53:124-44. doi: 10.1016/j.plipres.2013.12.001. Epub 2013 Dec 18.

引用本文的文献

1
Aerobic Exercise Delays Age-Related Sarcopenia in Mice via Alleviating Imbalance in Mitochondrial Quality Control.有氧运动通过减轻线粒体质量控制失衡延缓小鼠与年龄相关的肌肉减少症。
Metabolites. 2025 Jul 11;15(7):472. doi: 10.3390/metabo15070472.
2
Gui-Pi-Tang Defers Skeletal Muscle and Cardiac Muscle Aging by Promoting Mitochondrial Remodeling.归脾汤通过促进线粒体重塑延缓骨骼肌和心肌衰老。
Drug Des Devel Ther. 2025 Apr 21;19:3059-3076. doi: 10.2147/DDDT.S509046. eCollection 2025.
3
A Narrative Review on the Impact of Probiotic Supplementation on Muscle Development, Metabolic Regulation, and Fiber Traits Related to Meat Quality in Broiler Chickens.

本文引用的文献

1
Rosiglitazone ameliorates skeletal muscle insulin resistance by decreasing free fatty acids release from adipocytes.罗格列酮通过减少脂肪细胞游离脂肪酸的释放来改善骨骼肌胰岛素抵抗。
Biochem Biophys Res Commun. 2020 Dec 17;533(4):1122-1128. doi: 10.1016/j.bbrc.2020.09.144. Epub 2020 Oct 6.
2
PPARs and Angiogenesis-Implications in Pathology.过氧化物酶体增殖物激活受体与血管生成——病理学意义。
Int J Mol Sci. 2020 Aug 10;21(16):5723. doi: 10.3390/ijms21165723.
3
Peroxisome Proliferator-Activated Receptors and Their Novel Ligands as Candidates for the Treatment of Non-Alcoholic Fatty Liver Disease.
益生菌补充剂对肉鸡肌肉发育、代谢调节及与肉质相关的纤维特性影响的叙述性综述
Microorganisms. 2025 Mar 28;13(4):784. doi: 10.3390/microorganisms13040784.
4
Integrative Analysis of ATAC-Seq and RNA-Seq Identifies Key Genes Affecting Muscle Development in Ningxiang Pigs.ATAC-Seq和RNA-Seq的综合分析鉴定出影响宁乡猪肌肉发育的关键基因。
Int J Mol Sci. 2025 Mar 14;26(6):2634. doi: 10.3390/ijms26062634.
5
Peroxisome proliferator-activated receptor-α affects corneal epithelial wound healing.过氧化物酶体增殖物激活受体-α影响角膜上皮伤口愈合。
Mol Vis. 2024 Dec 4;30:410-420. eCollection 2024.
6
Distinct Impact of Doxorubicin on Skeletal Muscle and Fat Metabolism in Mice: Without Dexrazoxane Effect.多柔比星对小鼠骨骼肌和脂肪代谢的独特影响:无右丙亚胺作用。
Int J Mol Sci. 2025 Jan 29;26(3):1177. doi: 10.3390/ijms26031177.
7
Deubiquitinating Enzyme USP2 Alleviates Muscle Atrophy by Stabilizing PPAR-γ.去泛素化酶USP2通过稳定PPAR-γ减轻肌肉萎缩。
Diabetes. 2025 May 1;74(5):773-786. doi: 10.2337/db24-0375.
8
Exploring the Role of Peroxisome Proliferator-Activated Receptors and Endothelial Dysfunction in Metabolic Dysfunction-Associated Steatotic Liver Disease.探索过氧化物酶体增殖物激活受体与内皮功能障碍在代谢功能障碍相关脂肪性肝病中的作用
Cells. 2024 Dec 12;13(24):2055. doi: 10.3390/cells13242055.
9
Transcriptomics and metabolomics insights into the seasonal dynamics of meat quality in yak on the Qinghai-Tibetan Plateau.转录组学和代谢组学揭示青藏高原牦牛肉质季节性动态变化
BMC Genomics. 2024 Dec 18;25(1):1194. doi: 10.1186/s12864-024-11093-5.
10
Transcriptome sequencing analysis reveals the molecular mechanism of sepsis-induced muscle atrophy.转录组测序分析揭示了脓毒症诱导的肌肉萎缩的分子机制。
J Thorac Dis. 2024 Nov 30;16(11):7751-7770. doi: 10.21037/jtd-24-1665. Epub 2024 Nov 29.
过氧化物酶体增殖物激活受体及其新型配体作为非酒精性脂肪性肝病治疗的候选药物。
Cells. 2020 Jul 8;9(7):1638. doi: 10.3390/cells9071638.
4
PPAR Beta/Delta and the Hallmarks of Cancer.过氧化物酶体增殖物激活受体-β/δ 与癌症的特征。
Cells. 2020 May 4;9(5):1133. doi: 10.3390/cells9051133.
5
At the Crossroads of the Adipocyte and Osteoclast Differentiation Programs: Future Therapeutic Perspectives.在脂肪细胞和破骨细胞分化程序的十字路口:未来的治疗前景。
Int J Mol Sci. 2020 Mar 26;21(7):2277. doi: 10.3390/ijms21072277.
6
Stem Cell Aging in Skeletal Muscle Regeneration and Disease.干细胞衰老在骨骼肌再生和疾病中的作用。
Int J Mol Sci. 2020 Mar 6;21(5):1830. doi: 10.3390/ijms21051830.
7
PPAR-Mediated Toxicology and Applied Pharmacology.过氧化物酶体增殖物激活受体介导的毒理学与应用药理学。
Cells. 2020 Feb 3;9(2):352. doi: 10.3390/cells9020352.
8
The Role of the Gut Microbiome on Skeletal Muscle Mass and Physical Function: 2019 Update.肠道微生物群对骨骼肌质量和身体功能的作用:2019年更新
Front Physiol. 2019 Nov 26;10:1435. doi: 10.3389/fphys.2019.01435. eCollection 2019.
9
Peroxisome proliferator-activated receptor agonists and antagonists: a patent review (2014-present).过氧化物酶体增殖物激活受体激动剂和拮抗剂:专利审查(2014 年至今)。
Expert Opin Ther Pat. 2020 Jan;30(1):1-13. doi: 10.1080/13543776.2020.1703952. Epub 2019 Dec 18.
10
Exploration and Development of PPAR Modulators in Health and Disease: An Update of Clinical Evidence.PPAR 调节剂在健康与疾病中的探索与开发:临床证据的更新。
Int J Mol Sci. 2019 Oct 11;20(20):5055. doi: 10.3390/ijms20205055.